Characterization and disruption of bacterial microcompartment shells from human pathogens

NIH RePORTER · NIH · R01 · $469,091 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract: Many pathogenic bacteria utilize protein-based nanoreactors called bacterial microcompartments to metabolize diverse nutritional sources. This helps pathogenic organisms thrive in human tissues. The bacterial microcompartment is a specialized organelle composed of enzymes surrounded by a protein shell. To function, compounds to be broken down within the bacterial microcompartment must cross the shell and, likewise, the breakdown products must egress the compartments. The goal of the proposed research is to study and disrupt the protein-protein interactions essential for shell integrity. In parallel, we will characterize the permeability properties of BMC shells, and screen for compounds that interfere with flux across the shells. Collectively these data will provide new knowledge about the structural basis of shell function and provide the foundation for producing therapeutics that disrupt shell assembly and permeability.

Key facts

NIH application ID
9850079
Project number
5R01AI114975-06
Recipient
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
Principal Investigator
Cheryl A Kerfeld
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$469,091
Award type
5
Project period
2015-01-01 → 2022-01-31